Carlsmed (CARL) Cash from Investing Activities (2024 - 2026)

Carlsmed (CARL) has reported Cash from Investing Activities for 3 consecutive years, with -$19.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 2825.15% year-over-year to -$19.7 million; the trailing twelve-month figure through Jun 2026 stood at -$44.4 million (down 4243.7% YoY), and the FY2025 full-year result was -$25.5 million, down 14057.22% from the prior year.
• Cash from Investing Activities slipped to -$19.7 million in Q2 2026 per CARL's latest filing, from -$206000.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$52000.0 in Q3 2024 and bottomed at -$24.2 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged -$5.7 million across 3 years, with a median of -$290500.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities sank 39621.31% in 2025, then grew 13.45% in 2026.
• Over 3 years, Cash from Investing Activities stood at -$61000.0 in 2024, then tumbled by 39621.31% to -$24.2 million in 2025, then advanced by 18.87% to -$19.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$19.7 million, -$206000.0, and -$24.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.